Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -11,479 | -8,435 | -13,731 |
| Depreciation Amortization | 317 | 206 | 431 |
| Accounts receivable | -414 | -418 | N/A |
| Accounts payable and accrued liabilities | -91 | 476 | N/A |
| Other Working Capital | -435 | -96 | -159 |
| Other Operating Activity | 727 | 78 | 269 |
| Operating Cash Flow | $-11,375 | $-8,189 | $-13,190 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -415 | -415 | -653 |
| Investing Cash Flow | $-415 | $-415 | $-653 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | 9,430 | 9,430 | 1 |
| Financing Cash Flow | $9,430 | $9,430 | $1 |
| Beginning Cash Position | 8,262 | 8,262 | 22,104 |
| End Cash Position | 5,902 | 9,088 | 8,262 |
| Net Cash Flow | $-2,360 | $826 | $-13,842 |
| Free Cash Flow | |||
| Operating Cash Flow | -11,375 | -8,189 | -13,190 |
| Capital Expenditure | -415 | -415 | N/A |
| Free Cash Flow | -11,790 | -8,604 | -13,190 |